NEW
Stock Screener with Intrinsic Value
Regeneron Pharmaceuticals, Inc. (REGN)
Last Price$696.9(5.0%)
Market Cap$75.6B
5.7%
Industry median - 13.4%
5Y Historical average - 17.0%
(5.1%)
Industry median - 1.1%
5Y Historical average - 25.9%
15.7%
Industry median - (20.2%)
5Y Historical average - 25.9%
(26.7%)
Industry median - (1.2%)
5Y Historical average - 45.3%
REGN Growth Rating
Crunching data... Almost there!
REGN Growth Metrics
Crunching data... Almost there!
Competing with REGN Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Regeneron Pharmaceuticals, Inc. (REGN) revenue growth?
The Regeneron Pharmaceuticals, Inc. (REGN) revenue growth is 5.7%, which is lower than the industry median of 13.4% and the 5-year historical average of 17.0%.
What is the Regeneron Pharmaceuticals, Inc. (REGN) operating income growth?
The Regeneron Pharmaceuticals, Inc. (REGN) operating income growth is (5.1%), compared to the industry median of 1.1% and the 5-year historical average of 25.9%.
What is the Regeneron Pharmaceuticals, Inc. (REGN) EPS (Earnings Per Share) growth?
The Regeneron Pharmaceuticals, Inc. (REGN) EPS growth is 15.7%, compared to the industry median of (20.2%) and the 5-year historical average of 25.9%.
What is the Regeneron Pharmaceuticals, Inc. (REGN) Free Cash Flow (FCF) growth?
The Regeneron Pharmaceuticals, Inc. (REGN) Free Cash Flow growth is (26.7%), compared to the industry median of (1.2%) and the 5-year historical average of 45.3%.